{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:40:31Z","timestamp":1792525231235,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07201-y","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:35:23Z","timestamp":1784878523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferritin and LDH predict thrombotic risk beyond conventional scoring systems in DLBCL"],"prefix":"10.1007","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8342-990X","authenticated-orcid":false,"given":"Bu\u011fra","family":"Sa\u011flam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4025-741X","authenticated-orcid":false,"given":"Murat","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9596-4042","authenticated-orcid":false,"given":"Abdulkerim","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3829-289X","authenticated-orcid":false,"given":"P\u0131nar","family":"T\u0131\u011fl\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4111-2004","authenticated-orcid":false,"given":"Mesut","family":"T\u0131\u011fl\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9161-5582","authenticated-orcid":false,"given":"Merih Reis","family":"Aras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6112-3950","authenticated-orcid":false,"given":"Fatma","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9386-7604","authenticated-orcid":false,"given":"Hatice Berna Afacan","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"3","key":"7201_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","volume":"4","author":"Jw Blom","year":"2006","unstructured":"BLOM JW, Vanderschoot J, Oostindier M, Van Der Meer OSANTOS, Rosendaal F F (2006) Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study. J Thromb Haemost 4(3):529\u2013535. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01804.x","journal-title":"J Thromb Haemost"},{"key":"7201_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.thromres.2016.05.008","volume":"143","author":"K Sanfilippo","year":"2016","unstructured":"Sanfilippo K, Wang T, Gage B, Luo S, Riedell P, Carson K (2016) Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma. Thromb Res 143:86\u201390. https:\/\/doi.org\/10.1016\/j.thromres.2016.05.008","journal-title":"Thromb Res"},{"issue":"3","key":"7201_CR3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","volume":"5","author":"A Khorana","year":"2007","unstructured":"Khorana A, Francis C, Culakova E, Kuderer N, Lyman G (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5(3):632\u2013634. https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02374.x","journal-title":"J Thromb Haemost"},{"issue":"15","key":"7201_CR4","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/archinte.164.15.1653","volume":"164","author":"LS Elting","year":"2004","unstructured":"Elting LS, Escalante CP, Cooksley C, Avritscher EB, Kurtin D, Hamblin L, Khosla SG, Rivera E (2004) Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med 164(15):1653\u20131661. https:\/\/doi.org\/10.1001\/archinte.164.15.1653","journal-title":"Arch Intern Med"},{"issue":"4","key":"7201_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/13696998.2019.1703190","volume":"23","author":"AA Khorana","year":"2020","unstructured":"Khorana AA, McCrae KR, Milentijevic D, Lalibert\u00e9 F, Lejeune D, Crivera C, Lefebvre P (2020) Healthcare resource utilization and costs associated with venous thromboembolism recurrence in patients with cancer. J Med Econ 23(4):323\u2013329. https:\/\/doi.org\/10.1080\/13696998.2019.1703190","journal-title":"J Med Econ"},{"issue":"2","key":"7201_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4103\/jcrt.JCRT_121_18","volume":"15","author":"H Wang","year":"2019","unstructured":"Wang H, Xu X, Pu C, Li L (2019) Clinical characteristics and prognosis of cancer patients with venous thromboembolism. J Cancer Res Ther 15(2):344\u2013349. https:\/\/doi.org\/10.4103\/jcrt.JCRT_121_18","journal-title":"J Cancer Res Ther"},{"issue":"8","key":"7201_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1515\/cclm-2014-1010","volume":"53","author":"M Franchini","year":"2015","unstructured":"Franchini M (2015) Thromboembolic risk in hematological malignancies. Clinical Chemistry and Laboratory Medicine (CCLM) 53(8):1139\u20131147. https:\/\/doi.org\/10.1515\/cclm-2014-1010","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"6","key":"7201_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1470-2045(05)70207-2","volume":"6","author":"P Prandoni","year":"2005","unstructured":"Prandoni P, Falanga A, Piccioli A (2005) Cancer and venous thromboembolism. Lancet Oncol 6(6):401\u2013410 https:\/\/doi.org\/10.1016\/S1470-2045(05)70207-2","journal-title":"Lancet Oncol"},{"key":"7201_CR9","doi-asserted-by":"crossref","unstructured":"Khorana AA, Dalal MR, Lin J, Connolly GC (2013) Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States. ClinicoEconomics and Outcomes Research 5:101\u2013108. https:\/\/doi.org\/10.2147\/CEOR.S39964","DOI":"10.2147\/CEOR.S39964"},{"issue":"2","key":"7201_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02981929","volume":"73","author":"A Falanga","year":"2001","unstructured":"Falanga A, Benedetta Donati M (2001) Pathogenesis of thrombosis in patients with malignancy. Int J Hematol 73(2):137\u2013144. https:\/\/doi.org\/10.1007\/BF02981929","journal-title":"Int J Hematol"},{"issue":"7","key":"7201_CR11","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","volume":"23","author":"D Farge","year":"2022","unstructured":"Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Mu\u00f1oz A, Brenner B, Prata PH, Brilhante D (2022) 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol 23(7):e334\u2013e347. https:\/\/doi.org\/10.1016\/S1470-2045(22)00160-7","journal-title":"Lancet Oncol"},{"issue":"12","key":"7201_CR12","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1002\/cncr.21496","volume":"104","author":"AA Khorana","year":"2005","unstructured":"Khorana AA, Francis CW, Culakova E, Lyman GH (2005) Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer: Interdisciplinary Int J Am Cancer Soc 104(12):2822\u20132829. https:\/\/doi.org\/10.1002\/cncr.21496","journal-title":"Cancer: Interdisciplinary Int J Am Cancer Soc"},{"issue":"2","key":"7201_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/annonc\/mdj068","volume":"17","author":"K Kr\u00f6ger","year":"2006","unstructured":"Kr\u00f6ger K, Weiland D, Ose C, Neumann N, Weiss S, Hirsch C, Urbanski K, Seeber S, Scheulen M (2006) Risk factors for venous thromboembolic events in cancer patients. Ann Oncol 17(2):297\u2013303. https:\/\/doi.org\/10.1093\/annonc\/mdj068","journal-title":"Ann Oncol"},{"issue":"6","key":"7201_CR14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/archinte.160.6.809","volume":"160","author":"JA Heit","year":"2000","unstructured":"Heit JA, Silverstein MD, Mohr DN, Petterson TM, O\u2019Fallon WM, Melton LJ (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160(6):809\u2013815. https:\/\/doi.org\/10.1001\/archinte.160.6.809","journal-title":"Arch Intern Med"},{"issue":"10","key":"7201_CR15","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood J Am Soc Hematol 111(10):4902\u20134907. https:\/\/doi.org\/10.1182\/blood-2007-10-116327","journal-title":"Blood J Am Soc Hematol"},{"issue":"3","key":"7201_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"Cancer J Clin"},{"key":"7201_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.738693","volume":"8","author":"W Cai","year":"2021","unstructured":"Cai W, Zeng Q, Zhang X, Ruan W (2021) Trends analysis of non-Hodgkin lymphoma at the national, regional, and global level, 1990\u20132019: results from the global burden of disease study 2019. Front Med 8:738693. https:\/\/doi.org\/10.3389\/fmed.2021.738693","journal-title":"Front Med"},{"issue":"1","key":"7201_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.amjmed.2005.06.058","volume":"119","author":"PD Stein","year":"2006","unstructured":"Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE (2006) Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 119(1):60\u201368. https:\/\/doi.org\/10.1016\/j.amjmed.2005.06.058","journal-title":"Am J Med"},{"issue":"3","key":"7201_CR19","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1200\/JOP.2015.004473","volume":"11","author":"GH Lyman","year":"2015","unstructured":"Lyman GH, Bohlke K, Falanga A (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Oncol Pract 11(3):e442\u2013e444.\u00a0https:\/\/doi.org\/10.1200\/JOP.2015.004473","journal-title":"J Oncol Pract"},{"issue":"4","key":"7201_CR20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1538-7836.2004.00689.x","volume":"2","author":"P Reitsma","year":"2004","unstructured":"Reitsma P, Rosendaal F (2004) Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost 2(4):619\u2013622. https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00689.x","journal-title":"J Thromb Haemost"},{"issue":"7","key":"7201_CR21","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/01.ATV.0000170133.43608.37","volume":"25","author":"SF Mause","year":"2005","unstructured":"Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C (2005) Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 25(7):1512\u20131518. https:\/\/doi.org\/10.1161\/01.ATV.0000170133.43608.37","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"7201_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3892\/mmr.2013.1344","volume":"7","author":"W Lv","year":"2013","unstructured":"Lv W, Duan Q, Wang L, Gong Z, Yang F, Song Y (2013) Gene expression levels of cytokines in peripheral blood mononuclear cells from patients with pulmonary embolism. Mol Med Rep 7(4):1245\u20131250. https:\/\/doi.org\/10.3892\/mmr.2013.1344","journal-title":"Mol Med Rep"},{"issue":"11","key":"7201_CR23","first-page":"673","volume":"1","author":"A Falanga","year":"2003","unstructured":"Falanga A, Marchetti M, Vignoli A, Balducci D (2003) Clotting mechanisms and cancer: implications in thrombus formation and tumor progression. Clin Adv Hematol oncology: H&O1(11):673\u2013678","journal-title":"Clin Adv Hematol oncology: H&O"},{"issue":"1\u20132","key":"7201_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000046585","volume":"106","author":"MB Donati","year":"2001","unstructured":"Donati MB, Falanga A (2001) Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematol 106(1\u20132):18\u201324. https:\/\/doi.org\/10.1159\/000046585","journal-title":"Acta Haematol"},{"key":"7201_CR25","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/S0049-3848(14)50004-7","volume":"133","author":"A Mahajan","year":"2014","unstructured":"Mahajan A, Wun T, Chew H, White RH (2014) Lymphoma and venous thromboembolism: influence on mortality. Thromb Res 133:S23\u2013S28. https:\/\/doi.org\/10.1016\/S0049-3848(14)50004-7","journal-title":"Thromb Res"},{"issue":"2","key":"7201_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1177\/1078155219851540","volume":"26","author":"A Y\u0131ld\u0131z","year":"2020","unstructured":"Y\u0131ld\u0131z A, Albayrak M, Pala \u00c7, Afacan \u00d6zt\u00fcrk HB, Maral S, \u015eahin O, C\u00f6mert P (2020) The incidence and risk factors of thrombosis and the need for thromboprophylaxis in lymphoma and leukemia patients: a 9-year single-center experience. J Oncol Pharm Pract 26(2):386\u2013396. https:\/\/doi.org\/10.1177\/1078155219851540","journal-title":"J Oncol Pharm Pract"},{"issue":"12","key":"7201_CR27","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1002\/cncr.34210","volume":"128","author":"R Gangaraju","year":"2022","unstructured":"Gangaraju R, Davis ES, Bhatia S, Kenzik KM (2022) Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma. Cancer 128(12):2348\u20132357. https:\/\/doi.org\/10.1002\/cncr.34210","journal-title":"Cancer"},{"issue":"26","key":"7201_CR28","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1182\/blood-2010-01-258624","volume":"115","author":"V Caruso","year":"2010","unstructured":"Caruso V, Di Castelnuovo A, Meschengieser S, Lazzari MA, De Gaetano G, Storti S, Iacoviello L, Donati MB (2010) Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events. Blood 115(26):5322\u20135328. https:\/\/doi.org\/10.1182\/blood-2010-01-258624","journal-title":"Blood"},{"issue":"3","key":"7201_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/107327481201900305","volume":"19","author":"JL Cultrera","year":"2012","unstructured":"Cultrera JL, Dalia SM (2012) Diffuse large B-cell lymphoma: current strategies and future directions. Cancer Control 19(3):204\u2013213. https:\/\/doi.org\/10.1177\/107327481201900305","journal-title":"Cancer Control"},{"issue":"8","key":"7201_CR30","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/sj.bjc.6602504","volume":"92","author":"M Mohren","year":"2005","unstructured":"Mohren M, Markmann I, Jentsch-Ullrich K, Koenigsmann M, Lutze G, Franke A (2005) Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis. Br J Cancer 92(8):1349\u20131351. https:\/\/doi.org\/10.1038\/sj.bjc.6602504","journal-title":"Br J Cancer"},{"issue":"1","key":"7201_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.thromres.2011.09.022","volume":"130","author":"K Yokoyama","year":"2012","unstructured":"Yokoyama K, Murata M, Ikeda Y, Okamoto S (2012) Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma. Thromb Res 130(1):7\u201311. https:\/\/doi.org\/10.1016\/j.thromres.2011.09.022","journal-title":"Thromb Res"},{"issue":"3","key":"7201_CR32","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.thromres.2012.03.019","volume":"130","author":"LC Park","year":"2012","unstructured":"Park LC, Woo S-y, Kim S, Jeon H, Ko YH, Kim SJ, Kim WS (2012) Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population. Thromb Res 130(3):e6\u2013e12. https:\/\/doi.org\/10.1016\/j.thromres.2012.03.019","journal-title":"Thromb Res"},{"issue":"5","key":"7201_CR33","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.thromres.2015.09.001","volume":"136","author":"JL Lund","year":"2015","unstructured":"Lund JL, \u00d8stg\u00e5rd LS, Prandoni P, S\u00f8rensen HT, de Nully Brown P (2015) Incidence, determinants and the transient impact of cancer treatments on venous thromboembolism risk among lymphoma patients in Denmark. Thromb Res 136(5):917\u2013923. https:\/\/doi.org\/10.1016\/j.thromres.2015.09.001","journal-title":"Thromb Res"},{"issue":"24","key":"7201_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70510","volume":"13","author":"W Li","year":"2024","unstructured":"Li W, Liu R, Shen Y, Gao G, Yang R, Wang Y, Yang R, Lin Z, Dong R, Zhao W (2024) Incidence, risk factors, and modified risk assessment model of venous thromboembolism in non-Hodgkin lymphoma patients. Cancer Med 13(24):e70510. https:\/\/doi.org\/10.1002\/cam4.70510","journal-title":"Cancer Med"},{"issue":"8","key":"7201_CR35","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ajh.25837","volume":"95","author":"G Dharmavaram","year":"2020","unstructured":"Dharmavaram G, Cao S, Sundaram S, Ayyappan S, Boughan K, Gallogly M, Malek E, Metheny L, Tomlinson B, Otegbeye F (2020) Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma-specific venous thrombosis prediction models. Am J Hematol 95(8):918\u2013926. https:\/\/doi.org\/10.1002\/ajh.25837","journal-title":"Am J Hematol"},{"issue":"10","key":"7201_CR36","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/ajh.24466","volume":"91","author":"D Antic","year":"2016","unstructured":"Antic D, Milic N, Nikolovski S, Todorovic M, Bila J, Djurdjevic P, Andjelic B, Djurasinovic V, Sretenovic A, Vukovic V (2016) Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients. Am J Hematol 91(10):1014\u20131019. https:\/\/doi.org\/10.1002\/ajh.24466","journal-title":"Am J Hematol"},{"issue":"5\u20136","key":"7201_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/10428199509059641","volume":"18","author":"K Morikawa","year":"1995","unstructured":"Morikawa K, Oseko F, Morikawa S (1995) A role for ferritin in hematopoiesis and the immune system. Leuk Lymphoma 18(5\u20136):429\u2013433. https:\/\/doi.org\/10.3109\/10428199509059641","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"7201_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxx031","volume":"29","author":"KF Kernan","year":"2017","unstructured":"Kernan KF, Carcillo JA (2017) Hyperferritinemia and inflammation. Int Immunol 29(9):401\u2013409. https:\/\/doi.org\/10.1093\/intimm\/dxx031","journal-title":"Int Immunol"},{"issue":"1","key":"7201_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/ijlh.12592","volume":"39","author":"S Koyama","year":"2017","unstructured":"Koyama S, Fujisawa S, Watanabe R, Itabashi M, Ishibashi D, Ishii Y, Hattori Y, Nakajima Y, Motohashi K, Takasaki H (2017) Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma. Int J Lab Hematol 39(1):112\u2013117. https:\/\/doi.org\/10.1111\/ijlh.12592","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"7201_CR40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s12185-019-02816-6","volume":"111","author":"DJ Kim","year":"2020","unstructured":"Kim DJ, Kim T, Jeong J-Y, Jo J-C, Lee WS, Shin H-J, Lee JH, Lee HS (2020) Poor prognostic impact of high serum ferritin levels in patients with a lower risk of diffuse large B cell lymphoma. Int J Hematol 111(4):559\u2013566. https:\/\/doi.org\/10.1007\/s12185-019-02816-6","journal-title":"Int J Hematol"},{"key":"7201_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.823079","volume":"11","author":"Z Shen","year":"2022","unstructured":"Shen Z, Zhang S, Zhang M, Hu L, Sun Q, He C, Yan D, Ye J, Zhang H, Wang L (2022) The addition of ferritin enhanced the prognostic value of international prognostic index in diffuse large B-cell lymphoma. Front Oncol 11:823079. https:\/\/doi.org\/10.3389\/fonc.2021.823079","journal-title":"Front Oncol"},{"issue":"11","key":"7201_CR42","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.2174\/138161212799504731","volume":"18","author":"K Aksu","year":"2012","unstructured":"Aksu K, Donmez A, Keser G (2012) Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Design 18(11):1478\u20131493. https:\/\/doi.org\/10.2174\/138161212799504731","journal-title":"Curr Pharm Design"},{"issue":"20","key":"7201_CR43","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1161\/01.CIR.0000066910.02844.D0","volume":"107","author":"SM Day","year":"2003","unstructured":"Day SM, Duquaine D, Mundada LV, Menon RG, Khan BV, Rajagopalan S, Fay WP (2003) Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 107(20):2601\u20132606. https:\/\/doi.org\/10.1161\/01.CIR.0000066910.02844.D0","journal-title":"Circulation"},{"issue":"12","key":"7201_CR44","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1161\/01.ATV.0000190610.63878.20","volume":"25","author":"M Nanami","year":"2005","unstructured":"Nanami M, Ookawara T, Otaki Y, Ito K, Moriguchi R, Miyagawa K, Hasuike Y, Izumi M, Eguchi H, Suzuki K (2005) Tumor necrosis factor-\u03b1\u2013induced iron sequestration and oxidative stress in human endothelial cells. Arterioscler Thromb Vasc Biol 25(12):2495\u20132501. https:\/\/doi.org\/10.1161\/01.ATV.0000190610.63878.20","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"7201_CR45","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00277-022-04813-y","volume":"101","author":"M Lucijanic","year":"2022","unstructured":"Lucijanic M, Demaria M, Gnjidic J, Rob Z, Filipovic D, Penovic T, Jordan A, Barisic-Jaman M, Pastrovi\u0107 F, Lucijanic D (2022) Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis. Ann Hematol 101(5):1119\u20131121. https:\/\/doi.org\/10.1007\/s00277-022-04813-y","journal-title":"Ann Hematol"},{"issue":"1","key":"7201_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-185","volume":"11","author":"C Ros\u00e1rio","year":"2013","unstructured":"Ros\u00e1rio C, Zandman-Goddard G, Meyron-Holtz EG, D\u2019Cruz DP, Shoenfeld Y (2013) The hyperferritinemic syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med 11(1):185. https:\/\/doi.org\/10.1186\/1741-7015-11-185","journal-title":"BMC Med"},{"issue":"1","key":"7201_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-020-00228-7","volume":"25","author":"A Forkasiewicz","year":"2020","unstructured":"Forkasiewicz A, Dorociak M, Stach K, Szelachowski P, Tabola R, Augoff K (2020) The usefulness of lactate dehydrogenase measurements in current oncological practice. Cell Mol Biol Lett 25(1):35. https:\/\/doi.org\/10.1186\/s11658-020-00228-7","journal-title":"Cell Mol Biol Lett"},{"issue":"11","key":"7201_CR48","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1182\/blood.V108.11.2739.2739","volume":"108","author":"LH Sehn","year":"2006","unstructured":"Sehn LH, Chhanabhai M, Gill K, Hoskins P, Klasa R, Savage KJ, Shenkier T, Sutherland J, Gascoyne RD, Connors JM (2006) Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP-R Can Be Predicted by Stage and Serum Lactate Dehydrogenase (LDH) Level. Blood 108(11):2739.\u00a0https:\/\/doi.org\/10.1182\/blood.V108.11.2739.2739","journal-title":"Blood"},{"issue":"12","key":"7201_CR49","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41571-022-00686-2","volume":"19","author":"G Claps","year":"2022","unstructured":"Claps G, Faouzi S, Quidville V, Chehade F, Shen S, Vagner S, Robert C (2022) The multiple roles of LDH in cancer. Nat Rev Clin Oncol 19(12):749\u2013762. https:\/\/doi.org\/10.1038\/s41571-022-00686-2","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"7201_CR50","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-10-2828","volume":"71","author":"F V\u00e9gran","year":"2011","unstructured":"V\u00e9gran F, Boidot R, Michiels C, Sonveaux P, Feron O (2011) Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-\u03baB\/IL-8 pathway that drives tumor angiogenesis. Cancer Res 71(7):2550\u20132560. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2828","journal-title":"Cancer Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07201-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:01:48Z","timestamp":1792522908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07201-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7201"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07201-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9890529\/v1","asserted-by":"object"}]},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Clinical Research Ethics Committee of Ankara D\u0131\u015fkap\u0131 Y\u0131ld\u0131r\u0131m Beyaz\u0131t Training and Research Hospital (approval number 107\/30; date 22 March 2021). All procedures were performed in accordance with the 1964 Declaration of Helsinki and its later amendments.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Owing to the retrospective design of the study, the requirement for informed consent was waived by the ethics committee.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The manuscript contains no individual identifying data.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"466"}}